NYSE:BMY - Bristol-Myers Squibb Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $51.56 +0.64 (+1.26 %) (As of 12/19/2018 04:06 AM ET)Previous Close$50.92Today's Range$51.0550 - $52.0552-Week Range$46.94 - $70.05Volume8.24 million shsAverage Volume7.86 million shsMarket Capitalization$85.07 billionP/E Ratio17.13Dividend Yield3.07%Beta1.11 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Bristol-Myers Squibb (NYSE:BMY) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.19 Wall Street analysts have issued ratings and price targets for Bristol-Myers Squibb in the last 12 months. Their average twelve-month price target is $61.4019, suggesting that the stock has a possible upside of 19.09%. The high price target for BMY is $76.00 and the low price target for BMY is $47.00. There are currently 1 sell rating, 11 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.322.262.352.37Ratings Breakdown: 1 Sell Rating(s)11 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)12 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)11 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)12 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $61.4019$61.4019$62.6953$62.6519Price Target Upside: 19.09% upside15.27% upside3.92% upside16.15% upsideBristol-Myers Squibb (NYSE:BMY) Consensus Price Target History Bristol-Myers Squibb (NYSE:BMY) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails12/13/2018Credit Suisse GroupReiterated RatingHold$59.00High12/6/2018BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$60.00 ➝ $60.00High11/27/2018William BlairReiterated RatingOutperformMedium11/14/2018Societe GeneraleSet Price TargetSell$47.00Low11/6/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$63.00 ➝ $59.00Low10/23/2018Wolfe ResearchInitiated CoverageOutperform$66.00Low10/22/2018CitigroupDowngradeBuy ➝ Neutral$62.00 ➝ $57.00High10/12/2018BarclaysBoost Price TargetEqual Weight$55.00 ➝ $58.00Low10/8/2018GuggenheimInitiated CoverageNeutral ➝ NeutralLow10/8/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $74.00Medium8/8/2018Atlantic SecuritiesUpgradeUnderweight ➝ Neutral$57.00Medium7/31/2018SunTrust BanksReiterated RatingBuy$67.00Low7/15/2018Jefferies Financial GroupSet Price TargetHold$58.00Low5/21/2018UBS GroupDowngradeBuy ➝ Neutral$57.00Low4/20/2018CowenReiterated RatingHold$60.00Low4/17/2018Bank of AmericaLower Price TargetNeutral ➝ Neutral$68.00 ➝ $61.00Low3/21/2018ArgusLower Price TargetBuy$75.00 ➝ $66.43Low2/28/2018DZ BankDowngradeBuy ➝ HoldHigh2/6/2018Leerink SwannBoost Price TargetOutperform ➝ Positive$71.00 ➝ $76.00Medium10/27/2017Piper Jaffray CompaniesReiterated RatingHold$60.00N/A9/12/2017Hilliard LyonsDowngradeLong-term Buy ➝ Neutral$65.00Low9/7/2017Goldman Sachs GroupReiterated RatingBuy$62.00 ➝ $65.00Low7/17/2017Deutsche BankSet Price TargetHold$54.00 ➝ $55.00Low4/25/2017Robert W. BairdInitiated CoverageOutperformLow2/9/2017GabelliReiterated RatingBuyN/A1/8/2017Evercore ISIReiterated RatingHold$55.00N/A(Data available from 12/19/2016 forward) This page was last updated on 12/19/2018 by MarketBeat.com StaffFeatured Article: What is the LIBOR?